Wells Fargo analyst James Feldman maintains National Health Investors (NYSE:NHI) with a Overweight and raises the price target from $63 to $69.
Wells Fargo Maintains Overweight on National Health Investors, Raises Price Target to $69
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.